PercuSurge, MedNova, AngioGuard Battle For Inclusion In CREST Study

PercuSurge, AngioGuard and MedNova, three of the frontrunners in the race to have their distal protection devices used in the upcoming Carotid Revascularization Endarterectomy Stenting Trial (CREST), exhibited their wares at the Jan. 22-26 International Symposium on Endovascular Therapy (ISET) in Miami Beach.